These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4739914)

  • 1. Radioimmunoassay for measurement of thyroglobulin in human serum.
    Van Herle AJ; Uller RP; Matthews NI; Brown J
    J Clin Invest; 1973 Jun; 52(6):1320-7. PubMed ID: 4739914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
    Herle AJ; Uller RP
    J Clin Invest; 1975 Aug; 56(2):272-7. PubMed ID: 1150869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radioimmunoassay for serum rat thyroglobulin. Physiologic and pharmacological studies.
    Van Herle AJ; Klandorf H; Uller RP
    J Clin Invest; 1975 Nov; 56(5):1073-81. PubMed ID: 1184735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thyroglobulin in thyroid carcinoma and other thyroid disorders.
    Pacini F; Pinchera A; Giani C; Grasso L; Doveri F; Baschieri L
    J Endocrinol Invest; 1980; 3(3):283-92. PubMed ID: 7430557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radioimmunoassay for measurement of 3,3',5'-triiodothyronine (reverse T3).
    Chopra IJ
    J Clin Invest; 1974 Sep; 54(3):583-92. PubMed ID: 4211761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiple ligand-binding radioimmunoassay of diiodotyrosine.
    Nelson JC; Weiss RM; Lewis JE; Wilcox RB; Palmer FJ
    J Clin Invest; 1974 Feb; 53(2):416-22. PubMed ID: 11344555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroglobulin levels to follow-up patients with treated differentiated thyroid carcinoma.
    Moser E; Braun S; Büell U; Kirsch CM; Tosch U; Wendt T
    Cancer Detect Prev; 1984; 7(2):79-86. PubMed ID: 6424939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human thyroglobulin radioimmunoassay--Preliminary results in serum and thyroid tissue (author's transl)].
    Schlumberger M; Fragu P; Vignal A; Tubiana M
    Ann Endocrinol (Paris); 1979; 40(4):439-40. PubMed ID: 583204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical value of human thyroglobulin measurement].
    Merkelbach U; Burger A
    Schweiz Med Wochenschr; 1979 Nov; 109(42):1606-8. PubMed ID: 531548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay for measurement of triiodothyronine in human serum.
    Chopra IJ; Solomon DH; Beall GN
    J Clin Invest; 1971 Oct; 50(10):2033-41. PubMed ID: 4107265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies.
    Schneider AB; Pervos R
    J Clin Endocrinol Metab; 1978 Jul; 47(1):126-37. PubMed ID: 263287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodine-labeled proteins in the serum of patients treated with 131I for thyroid disease.
    Valenta L
    Endocrinol Exp; 1971 Jun; 5(3):127-42. PubMed ID: 5005942
    [No Abstract]   [Full Text] [Related]  

  • 13. High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management.
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2002 Dec; 46(4):319-22. PubMed ID: 12411872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay for estimation of thyroglobulin in human serum.
    Ochi Y; Hachiya T; Yoshimura M; Miyazaki T; Majima T
    Endocrinol Jpn; 1975 Aug; 22(4):351-6. PubMed ID: 1201740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum triiodothyronine and thyroxine in the neonate and the acute increases in these hormones following delivery.
    Abuid J; Stinson DA; Larsen PR
    J Clin Invest; 1973 May; 52(5):1195-9. PubMed ID: 4700492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].
    Rink T; Dembowski W; Schroth HJ; Klinger K
    Nuklearmedizin; 2000 Aug; 39(5):133-8. PubMed ID: 10984889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
    Weightman DR; Mallick UK; Fenwick JD; Perros P
    Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
    Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
    Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.